The tyrosine phosphorylation of EGFR was ablated in GRB7 knockdown ERBB2+ breast cancer, suggesting the effects of Grb7-mediated EGFR activation on the malignancy of ERBB2+ breast cancer [80]. The gene discussed is ERBB2; the disease is breast cancer.